Sep 29, 2022, 12:28 by

Monon Bioventures receives funding to develop glioblostoma treatment

Sep 29, 2022, 12:27 by

Sep 29, 2022, 01:00 by User Not Found

Clinical Research News | A first-of-its-kind benchtop platform that enables researchers to assess multiple critical quality attributes of cell samples in a single automated workflow; a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of numerous FDA-approved cancer therapies in new, biomarker-guided patient populations; and more.

Sep 28, 2022, 09:32 by

Sep 28, 2022, 09:31 by

Ceryx Medical Limited has announced a partnership with Berlin-based Osypka Medical to develop a heart pacing device that will change the way patients with heart failure and other cardiac conditions are treated.

Sep 28, 2022, 01:00 by User Not Found

Clinical Research News | Funding for comparative clinical effectiveness research for patients and caregivers, AI-based biomedical research, diversity in genomic research, and more.

Sep 27, 2022, 09:38 by

Sep 27, 2022, 09:38 by

Sep 27, 2022, 09:37 by

Sep 27, 2022, 09:35 by

Sep 27, 2022, 09:34 by

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Sep 23, 2022, 10:33 by

For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com

Sep 23, 2022, 10:32 by

Sep 23, 2022, 10:32 by

Sep 23, 2022, 10:32 by

Sep 23, 2022, 10:32 by

Sep 23, 2022, 10:31 by

Sep 23, 2022, 10:31 by

Sep 23, 2022, 10:31 by

Sep 23, 2022, 10:31 by